Cinemark’s (CNK) “Outperform” Rating Reaffirmed at Barrington Research

Barrington Research restated their outperform rating on shares of Cinemark (NYSE:CNK) in a research report report published on Thursday morning,Benzinga reports. They currently have a $32.00 target price on the stock.

Several other research analysts also recently issued reports on CNK. Roth Mkm reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Cinemark in a research note on Wednesday, November 5th. Wells Fargo & Company reduced their target price on shares of Cinemark from $33.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, January 14th. B. Riley Financial dropped their price target on shares of Cinemark from $35.00 to $29.00 and set a “neutral” rating for the company in a research note on Thursday, January 22nd. UBS Group upgraded shares of Cinemark to a “buy” rating in a report on Tuesday, January 20th. Finally, Benchmark restated a “buy” rating on shares of Cinemark in a report on Thursday, January 15th. Ten research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $32.08.

Cinemark Trading Down 0.0%

NYSE CNK opened at $26.41 on Thursday. The company has a market cap of $3.10 billion, a price-to-earnings ratio of 30.35, a price-to-earnings-growth ratio of 2.61 and a beta of 1.13. Cinemark has a twelve month low of $21.60 and a twelve month high of $34.01. The company has a quick ratio of 0.72, a current ratio of 0.76 and a debt-to-equity ratio of 4.53. The business’s fifty day moving average is $23.93 and its 200 day moving average is $25.88.

Cinemark (NYSE:CNK) last issued its earnings results on Wednesday, February 18th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.08). The firm had revenue of $776.30 million during the quarter, compared to analyst estimates of $778.41 million. Cinemark had a return on equity of 34.11% and a net margin of 4.44%.Cinemark’s revenue for the quarter was down 4.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.33 EPS. As a group, sell-side analysts expect that Cinemark will post 1.93 EPS for the current fiscal year.

Cinemark Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Tuesday, March 3rd will be given a $0.09 dividend. The ex-dividend date of this dividend is Tuesday, March 3rd. This represents a $0.36 annualized dividend and a dividend yield of 1.4%. Cinemark’s dividend payout ratio (DPR) is 34.62%.

Insider Activity at Cinemark

In related news, EVP Melissa Thomas sold 7,944 shares of the company’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $26.05, for a total transaction of $206,941.20. Following the sale, the executive vice president owned 159,416 shares in the company, valued at $4,152,786.80. This represents a 4.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Cinemark

A number of institutional investors and hedge funds have recently modified their holdings of CNK. Maryland State Retirement & Pension System increased its stake in shares of Cinemark by 3.1% in the 4th quarter. Maryland State Retirement & Pension System now owns 15,157 shares of the company’s stock valued at $352,000 after acquiring an additional 449 shares in the last quarter. Amalgamated Bank grew its holdings in Cinemark by 1.7% in the third quarter. Amalgamated Bank now owns 29,626 shares of the company’s stock worth $830,000 after purchasing an additional 488 shares during the period. Smartleaf Asset Management LLC grew its holdings in Cinemark by 20.1% in the third quarter. Smartleaf Asset Management LLC now owns 3,027 shares of the company’s stock worth $83,000 after purchasing an additional 506 shares during the period. Oregon Public Employees Retirement Fund increased its stake in Cinemark by 2.2% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 23,584 shares of the company’s stock valued at $548,000 after purchasing an additional 507 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Cinemark by 118.5% during the second quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock valued at $28,000 after purchasing an additional 507 shares during the period.

Key Headlines Impacting Cinemark

Here are the key news stories impacting Cinemark this week:

• Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $32 price target (~21% upside vs. current price), which supports upside sentiment among growth/value analysts. Barrington Research Reaffirmation
• Positive Sentiment: Cinemark announced a quarterly cash dividend of $0.09 per share (record/ex-dividend Mar 3; pay Mar 17), implying a ~1.4% yield — a modest positive for income-focused holders and a sign of management’s willingness to return cash.
• Positive Sentiment: Management outlined a ~$250M 2026 capex plan targeting higher box office, expansion of premium formats, and upgrades — investment that could drive larger ticket sales and higher margins long term. Capex Plan Article
• Neutral Sentiment: CEO comments on the Warner/Netflix theatrical window debate signaled cautious optimism — exhibitors see some encouragement from Netflix statements but remain wary, leaving theatrical demand exposure uncertain. CEO Netflix Comments
• Neutral Sentiment: Full Q4 earnings call transcript and investor slide deck were published (useful for detail on box office mix, international trends, and format rollouts). Earnings Call Transcript
• Negative Sentiment: Q4 results missed expectations: EPS $0.16 vs. consensus ~$0.45 and revenue $776.3M (vs. ~$778.4M); revenue was down ~4.7% year?over?year. The earnings shortfall and declining top line are the primary near-term drivers of downward pressure on the stock. Company Press Release
• Negative Sentiment: Analyst coverage notes and screens (Zacks, MarketBeat) highlight that Q4 results lagged estimates and EPS fell versus prior year, which could pressure sentiment until guidance or box-office momentum improves. Zacks Q4 Coverage

About Cinemark

Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in?theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate?owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large?format halls.

The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.